Call button

AAP, CPSC say decorated cribs pose suffocation risk to infants

Parents, this is a story you should read, especially if you’re using an older or used crib. The Wall Street Journal (4/19, Beck) reported that, according to the American Academy of Pediatrics and the Consumer Product Safety Commission, puffy bumpers, bedding, and stuffed animals all pose suffocation hazards to infants less than 12 months old. … Read more

Senators reach agreement on food safety bill

  This is good news for food safety, but it’s unfortunate it came too late to prevent the salmonella outbreak. The AP (8/13, Freking) reports, “A bipartisan group of senators said Thursday they have reached agreement on legislation designed to enhance the safety of the nation’s food supply,” which “would give the Food and Drug … Read more

FDA panel votes to keep Avandia on market with more restrictions

  ABC World News (7/14, story 5, 0:25, Sawyer) reported, “A surprise decision on Avandia [rosiglitazone]. Advisers to the Food and Drug Administration recommended keeping Avandia on the market,” although most “advisers did recommend stricter warning labels and the FDA will now decide which course to take.” The New York Times (7/15, A1, Harris) reports … Read more

Ask Marvin Lundy…About How to Buy Motorcycle Insurance

It’s spring. You’re looking forward to getting on the road. But, what happens if you’re in an accident? You may be the safest rider in the world, but what about the other guy? Who will pay your bills if you get hurt? Buying motorcycle insurance can be tricky. The rules are different state to state … Read more

Toyota suspends US sales of recalled models

  Have you seen the news? Toyota took the extraordinary step Tuesday of suspending the manufacture and sale of eight of its most popular models because of an unresolved issue over defective accelerators. The Japanese automaker told its dealers to temporarily stop selling the RAV4, Highlander and Sequoia sport-utility vehicles; Corolla, Camry and Avalon cars; … Read more

Asthma drug under review

July 16, 2009 The Associated Press reports, the Food and Drug Administration is investigating results from a study that indicate the asthma drug Xolair can cause heart attacks, strokes, and other potentially fatal side effects. Read More